Wang FH - Search Results

1

Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.

Ye LF, Huang ZY, Chen XX, Chen ZG, Wu SX, Ren C, Hu MT, Bao H, Jin Y, Wang F, Wang FH, Du ZM, Wu X, Ju HQ, Shao Y, Li YH, Xu RH, Wang DS. Ye LF, et al. Among authors: wang f, wang ds, wang fh. Drug Resist Updat. 2022 Dec;65:100883. doi: 10.1016/j.drup.2022.100883. Epub 2022 Sep 29. Drug Resist Updat. 2022. PMID: 36202008 Free article.

2

[Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].

Zhang DS, Jiang WQ, Li S, Zhang XS, Mao H, Chen XQ, Li YH, Zhan J, Wang FH. Zhang DS, et al. Among authors: wang fh. Ai Zheng. 2003 Aug;22(8):870-3. Ai Zheng. 2003. PMID: 12917038 Chinese.

3

[Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma].

He YF, Li YH, Huang HQ, Xia ZJ, Sun XF, Lin TY, Lin XB, Yuan ZY, Li ZM, Wang FH, Wang SS, Jiang WQ. He YF, et al. Among authors: wang ss, wang fh. Ai Zheng. 2005 Apr;24(4):475-7. Ai Zheng. 2005. PMID: 15820073 Chinese.

4

[Clinical analysis of liver damage of 116 malignant lymphoma patients with chronic HBV infection after cytotoxic chemotherapy].

Li YH, He YF, Wang FH, Lin XB, Xia ZJ, Sun XF, Lin TY, Huang HQ, Zhang L, Xu RH, Jiang WQ, Guan ZZ. Li YH, et al. Among authors: wang fh. Ai Zheng. 2005 Dec;24(12):1507-9. Ai Zheng. 2005. PMID: 16351802 Chinese.

5

[Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative].

Wang FH, Li YH, Li S, Jiang WQ, Guan ZZ. Wang FH, et al. Ai Zheng. 2006 Apr;25(4):501-4. Ai Zheng. 2006. PMID: 16613689 Clinical Trial. Chinese.

6

[Clinical pharmacokinetic trial of intravenous injection of recombinant human lymphotoxin-alpha derivative].

Li S, Wang FH, Liao H, Li YH, Jiang WQ, Guan ZZ. Li S, et al. Among authors: wang fh. Ai Zheng. 2006 Dec;25(12):1524-8. Ai Zheng. 2006. PMID: 17166379 Chinese.

7

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Li YH, Wang FH, Jiang WQ, Xiang XJ, Deng YM, Hu GQ, Xu DM, Chen Y, Lin Q, He YJ. Li YH, et al. Among authors: wang fh. Cancer Chemother Pharmacol. 2008 Aug;62(3):539-44. doi: 10.1007/s00280-007-0641-2. Epub 2008 Jan 3. Cancer Chemother Pharmacol. 2008. PMID: 18172651 Clinical Trial.

8

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.

He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ. He YF, et al. Among authors: wang fh. Ann Hematol. 2008 Jun;87(6):481-5. doi: 10.1007/s00277-008-0454-3. Epub 2008 Feb 26. Ann Hematol. 2008. PMID: 18299831

9

Clinical analysis of primary systemic anaplastic large cell lymphoma: a report of 57 cases.

Wang FH, Li YH, Zeng J, Rao HL, Xia ZJ, Sun XF, Huang HQ, Lin TY, Jiang WQ, Guan ZZ. Wang FH, et al. Ai Zheng. 2009 Jan;28(1):49-53. Epub 2009 Jan 15. Ai Zheng. 2009. PMID: 19448428 Free article.

10

Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.

An X, Li YH, Lin XB, Wang FH, Feng F, Xu RH, Jiang WQ, He YJ. An X, et al. Among authors: wang fh. Ai Zheng. 2009 Mar;28(3):286-91. Ai Zheng. 2009. PMID: 19619444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page